Delta Financial Group’s GSK GSK Stock Holding History

Delta Financial Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$300K	Sell	7,769 -145	-2%	-$5.31K	0.07%	192
2024 Q4	$268K	Buy	7,914 +133	+2%	+$4.79K	0.06%	207
2024 Q3	$318K	Sell	7,781 -100	-1%	-$4.09K	0.12%	96
2024 Q2	$303K	Hold	7,881	–	–	0.13%	94
2024 Q1	$338K	Sell	7,881 -128	-2%	-$5.28K	0.1%	162
2023 Q4	$297K	Hold	8,009	–	–	0.09%	162
2023 Q3	$290K	Hold	8,009	–	–	0.1%	155
2023 Q2	$285K	Sell	8,009 -240	-3%	-$8.61K	0.33%	65
2023 Q1	$293K	Hold	8,249	–	–	0.12%	130
2022 Q4	$289K	Buy	+8,249	New	+$275K	0.13%	119

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Delta Financial Group's GSK Position: Q1 2025 in Review

Delta Financial Group reduced its GSK (GSK) stake by 1.8% in Q1 2025, selling an estimated $5.31K and leaving 7,769 shares worth $300K. The position accounts for 0.07% of the portfolio, ranked #192.

Delta Financial Group first reported a position in GSK in Q4 2022 and has held it in 10 quarters since. The position peaked at $338K in Q1 2024. 857 funds tracked by Wall St. Rank hold GSK as of Q1 2025.

Delta Financial Group held 7,769 shares of GSK worth $300K as of Q1 2025.
Delta Financial Group sold 145 GSK shares in Q1 2025, an estimated $5.31K.
GSK made up 0.07% of Delta Financial Group's portfolio in Q1 2025, its #192 holding.
Delta Financial Group first reported a position in GSK in Q4 2022 and has held it in 10 quarters since.
Delta Financial Group's GSK position peaked at $338K in Q1 2024.
857 funds tracked by Wall St. Rank held GSK as of Q1 2025.

Based on Delta Financial Group's 13F filing for Q1 2025, filed 9 May 2025.